Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +4 vs. Q3 2024
- Shares held
- 24.6M
- −4.13M (−14.4%) vs. Q3 2024
- Total value
- $57.9M
- +$14.4M (+32.9%) vs. Q3 2024
- New holders
- 10
- 14 more added
- Sold out
- 6
- 14 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 100 | $236 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 100 | $236 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 329 | $776 | 0.00% | +329 | New |
| JPMorgan Chase & Co | 900 | $2.12K | 0.00% | +900 | New |
| Simplex Trading, LLC | 4,642 | $10.0K | 0.00% | +4,428+2,069.2% | Added |
| Advisor Group Holdings, Inc. | 6,934 | $16.4K | 0.00% | +434+6.7% | Added |
| Ancora Advisors, LLC | 10,000 | $23.6K | 0.00% | −50,000−83.3% | Reduced |
| Clear Creek Financial Management, LLC | 10,500 | $24.8K | 0.00% | −9,000−46.2% | Reduced |
| Jones Financial Companies LLLP | 11,000 | $26.0K | 0.00% | +10,000+1,000.0% | Added |
| Federation des caisses Desjardins du Quebec | 13,000 | $30.7K | 0.00% | +2,500+23.8% | Added |
| Beta Wealth Group, Inc. | 14,127 | $33.3K | 0.01% | 00.0% | Unchanged |
| Creative Planning | 14,180 | $33.5K | 0.00% | +1,100+8.4% | Added |
| Two Sigma Securities, LLC | 16,957 | $40.0K | 0.01% | −6,176−26.7% | Reduced |
| National Bank of Canada | 18,700 | $44.1K | 0.00% | +11,600+163.4% | Added |
| State Street Corp | 19,117 | $45.1K | 0.00% | −194−1.0% | Reduced |
| Geode Capital Management, LLC | 19,872 | $46.9K | 0.00% | +2,296+13.1% | Added |
| Valeo Financial Advisors, LLC | 20,000 | $47.2K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 24,731 | $58.4K | 0.00% | +60+0.2% | Added |
| Boothbay Fund Management, LLC | 30,790 | $72.7K | 0.00% | +110.0% | Added |
| Cubist Systematic Strategies, LLC | 30,938 | $73.0K | 0.00% | +30,938 | New |
| BNP Paribas Arbitrage, SA | 31,133 | $73.5K | 0.00% | +1,924+6.6% | Added |
| Susquehanna International Group, LLP | 33,092 | $78.1K | 0.00% | +33,092 | New |
| XTX Topco Ltd | 34,054 | $80.4K | 0.01% | +34,054 | New |
| Atria Investments LLC | 38,666 | $91.3K | 0.00% | −1,755−4.3% | Reduced |
| Dimensional Fund Advisors LP | 39,450 | $92.9K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 52,637 | $124.2K | 0.00% | +52,637 | New |
| Squarepoint Ops LLC | 56,751 | $133.9K | 0.00% | +2,506+4.6% | Added |
| Northern Trust Corp | 58,108 | $137.1K | 0.00% | +30,772+112.6% | Added |
| Envestnet Asset Management Inc | 63,742 | $150.4K | 0.00% | −6,848−9.7% | Reduced |
| Virtu Financial LLC | 71,955 | $170.0K | 0.01% | +71,955 | New |
| UBS Group AG | 89,506 | $211.2K | 0.00% | +89,506 | New |
| Boxer Capital Management, LLC | 309,007 | $729.3K | 0.06% | +309,007 | New |
| Ikarian Capital, LLC | 466,030 | $1.10M | 0.31% | +110.0% | Added |
| Stonepine Capital Management, LLC | 500,000 | $1.18M | 0.95% | −499,790−50.0% | Reduced |
| Citadel Advisors LLC | 608,202 | $1.44M | 0.00% | −1,453,320−70.5% | Reduced |
| Toronto Dominion Bank | 750,000 | $1.77M | 0.00% | +750,000 | New |
| Goldman Sachs Group Inc | 942,407 | $2.22M | 0.00% | −410,660−30.4% | Reduced |
| Lion Point Capital, LP | 1,025,806 | $2.42M | 12.68% | −628,348−38.0% | Reduced |
| BML Capital Management, LLC | 1,136,091 | $2.68M | 1.67% | 00.0% | Unchanged |
| Morgan Stanley | 1,289,141 | $3.04M | 0.00% | +370,829+40.4% | Added |
| Bleichroeder LP | 1,326,085 | $3.13M | 0.79% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,445,264 | $3.41M | 0.24% | −304,736−17.4% | Reduced |
| OrbiMed Advisors LLC | 2,000,000 | $4.72M | 0.10% | 00.0% | Unchanged |
| RTW Investments, LP | 2,506,102 | $5.91M | 0.09% | −750,000−23.0% | Reduced |
| Alta Fundamental Advisers LLC | 2,658,589 | $6.27M | 2.32% | 00.0% | Unchanged |
| Millennium Management LLC | 2,703,259 | $6.38M | 0.01% | −75,266−2.7% | Reduced |
| BlackRock, Inc. | 4,050,686 | $9.56M | 0.00% | −920,658−18.5% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −309,007−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −30,345−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −27,931−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −800−100.0% | Sold out |